CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes

Gang Luo, Mark R. Cunningham, Sean Kim, +17

Drug Metabolism and Disposition

Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery

Yutian Zou, Jindong Xie, Shaoquan Zheng, +10

International Journal of Surgery

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer

Yutian Zou, Feng Ye, Yanan Kong, +14

Advanced Science

Distant MetastasisSingle‐cell LandscapeImmunologyBiological MicroenvironmentsBreast Cancer Liver +18

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

Yutian Zou, Shaoquan Zheng, Xinhua Xie, +14

Nature Communications

Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions

Pingping Lin, Shichao Zhu, Yu Huang, +19

British Journal of Dermatology

Surrounding RegionsWorkplace Health SurveillanceHealthcare-associated InfectionCovid-19 PandemicAdverse Skin Reactions +6

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer

Xueqi Ou, Yeru Tan, Jindong Xie, +9

Drug Resistance Updates

Dissection of FOXO1-Induced LYPLAL1-DT Impeding Triple-Negative Breast Cancer Progression via Mediating hnRNPK/β-Catenin Complex

Yuhui Tang, W. H. Tian, Shaoquan Zheng, +9

Research

Breast OncologyCancer BiologyTumor BiologyTranscriptional RegulationSignaling Pathway +15

Circular RNA: A promising new star of vaccine

Jindong Xie, F. Ye, Xinpei Deng, +8

Journal of Translational Internal Medicine

Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature

Yuhui Tang, W. H. Tian, Jindong Xie, +9

Frontiers in Immunology

crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer

Yutian Zou, Anli Yang, Bo Chen, +9

Drug Resistance Updates

Tumor BiologyBreast OncologyMedicineHer2-low Breast CancerCrvdac3 Alleviates Ferroptosis +6